|
| 37741592 | Genetic variants and effect modifiers of QT interval prolongation in patients with sickle cell disease. | Gene | 2024 |
| 37488302 | Outcomes by disease onset, sex, and intervention in neonates with SIP and surgical NEC. | Pediatr Res | 2024 |
| 36893086 | Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach. | PLoS One | 2023 |
| 35347650 | Racial, Gender, and Neighborhood-Level Disparities in Pediatric Trauma Care. | J Racial Ethn Health Disparities | 2023 |
| 35396536 | Antihypertensive effects of immunosuppressive therapy in autoimmune disease. | J Hum Hypertens | 2023 |
| 35758856 | Higher hospitalization and mortality rates among SARS-CoV-2-infected persons in rural America. | J Rural Health | 2023 |
| 37461487 | Clinical impact of timing of surgery on outcomes in preterm infants with surgical necrotizing enterocolitis. | Res Sq | 2023 |
| 36950827 | Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified. | Catheter Cardiovasc Interv | 2023 |
| 37454184 | Gestational age-specific clinical correlates of acute kidney injury in preterm infants with necrotizing enterocolitis. | Pediatr Res | 2023 |
| 37293738 | Lower extremity symptoms and ankle-brachial index screening as predictors of cardiovascular outcomes in Black adults. | Vasc Med | 2023 |
| 36603014 | Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative. | PLoS One | 2023 |
| 36565070 | Clinical determinants and impact of hemorrhagic lesions on intestinal pathology in preterm infants with surgical necrotizing enterocolitis. | J Neonatal Perinatal Med | 2023 |
| 34103675 | Brain injury in preterm infants with surgical necrotizing enterocolitis: clinical and bowel pathological correlates. | Pediatr Res | 2022 |
| 35441823 | Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART). | Catheter Cardiovasc Interv | 2022 |
| 35819146 | Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy. | Catheter Cardiovasc Interv | 2022 |
| 35858647 | Clinical Correlates of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants following Surgical Necrotizing Enterocolitis. | Am J Perinatol | 2022 |
| 36521184 | Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years. | Catheter Cardiovasc Interv | 2022 |
| 36073636 | Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults. | J Am Heart Assoc | 2022 |
| 36093832 | Clinical impact of severe acute kidney injury on post-operative and brain injury outcomes in preterm infants following surgical necrotizing enterocolitis. | J Matern Fetal Neonatal Med | 2022 |
| 36378726 | Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure. | Catheter Cardiovasc Interv | 2022 |
| 36261134 | Clinical and histopathological correlates of intestinal repair in preterm infants following surgical necrotizing enterocolitis. | J Matern Fetal Neonatal Med | 2022 |
| 35316812 | Microwave Ablation for Malignant Central Airway Obstruction: A Pilot Study. | Respiration | 2022 |
| 34936591 | Social determinants of trauma care: Associations of race, insurance status, and place on opioid prescriptions, postdischarge referrals, and mortality. | J Trauma Acute Care Surg | 2022 |
| 33460268 | Everolimus eluting bioresorbable vascular scaffolds for infrapopliteal critical limb ischemia: Moving beyond grasping at metal straws. | Catheter Cardiovasc Interv | 2021 |
| 33851782 | Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care? | Catheter Cardiovasc Interv | 2021 |
| 33844843 | Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer. | Int J Cancer | 2021 |
| 33721413 | Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment. | Catheter Cardiovasc Interv | 2021 |
| 34752003 | Covered stents favored in complex aortoiliac disease. | Catheter Cardiovasc Interv | 2021 |
| 34596335 | Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward? | Catheter Cardiovasc Interv | 2021 |
| 34224382 | A New Method to Optimize Stent Deployment by High-Definition Intravascular Ultrasound. | J Invasive Cardiol | 2021 |
| 33966116 | The Association Between Neighborhood Social Vulnerability and COVID-19 Testing, Positivity, and Incidence in Alabama and Louisiana. | J Community Health | 2021 |
| 34369064 | Critical limb ischemia in the end stage renal disease patient: Some next steps. | Catheter Cardiovasc Interv | 2021 |
| 32159291 | A step forward in predicting anterograde crossing success for infrapopliteal chronic total occlusions. | Catheter Cardiovasc Interv | 2020 |
| 32042096 | Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. | Pharmacogenomics J | 2020 |
| 32034870 | Prior probability of significant obstructive arterial disease in the contralateral lower extremity. | Catheter Cardiovasc Interv | 2020 |
| 33085195 | A step toward physiologically guided chronic limb-threatening ischemia intervention. | Catheter Cardiovasc Interv | 2020 |
| 33306876 | Ticagrelor monotherapy: When is mono-antiplatelet therapy (MAPT) equivalent or better? | Catheter Cardiovasc Interv | 2020 |
| 33217186 | Radial access and risk guided use of bivalirudin? | Catheter Cardiovasc Interv | 2020 |
| 33156967 | Safety and efficacy of paclitaxel drug-coated balloon treatment of femoropopliteal claudicants: Data and analytic methods matter. | Catheter Cardiovasc Interv | 2020 |
| 32797736 | Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention. | Catheter Cardiovasc Interv | 2020 |
| 32924633 | Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study. | Hypertension | 2020 |
| 30719851 | Intravascular ultrasound of normal left main arteries: Insights for stent optimization and standardization. | Catheter Cardiovasc Interv | 2019 |
| 31701784 | Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention. | J Am Heart Assoc | 2019 |
| 31737991 | Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR). | Catheter Cardiovasc Interv | 2019 |
| 31025518 | Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present. | Catheter Cardiovasc Interv | 2019 |
| 29314640 | Patient preference: An important emerging factor in operator access site selection. | Catheter Cardiovasc Interv | 2018 |
| 30230206 | Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption. | Catheter Cardiovasc Interv | 2018 |
| 30917224 | Patent foramen ovale closure for cryptogenic stroke: Effective, but only in select patients. | Catheter Cardiovasc Interv | 2018 |
| 30312998 | "Expanding the frame" for valve-in-valve therapy in small bioprostheses: Encouraging signs for the road ahead. | Catheter Cardiovasc Interv | 2018 |
| 30478879 | Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta-analysis? | Catheter Cardiovasc Interv | 2018 |